Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats

Akio Itoh, Atsumi Nitta, Mitsuhiko Hirose, Takaaki Hasegawa, Toshitaka Nabeshima

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Several studies have indicated the possibility of using cholinesterase (ChE) inhibitors as therapeutic drugs for Alzheimer's disease. Metrifonate (MTF) is an organophosphorus compound that has been used in the treatment of schistosomiasis. In this study, we investigated the effects of MTF on the impairment of learning and memory, decreased ChE activity and extracellular acetylcholine (ACh) levels in basal forebrain (BF)-lesioned rats. The oral administration of MTF improved the BF-lesion-induced impairment of performance on passive avoidance task. Further, MTF reduced ChE activity in the cerebral cortex. In vivo brain microdialysis studies showed that MTF significantly increased the release of ACh, but decreased that of choline (Ch) in the cerebral cortex of BF-lesioned rats. These results indicated that MTF ameliorates the impairment of performance on passive avoidance task in BF-lesioned rats by increasing the extracellular ACh levels by inhibiting ChE. This suggested that MTF may be useful as a therapeutic drug for Alzheimer's disease.

Original languageEnglish
Pages (from-to)165-167
Number of pages3
JournalBehavioural Brain Research
Volume83
Issue number1-2
DOIs
Publication statusPublished - 01-01-1997
Externally publishedYes

Fingerprint

Trichlorfon
Cholinergic Agents
Learning
Cholinesterases
Acetylcholine
Cerebral Cortex
Alzheimer Disease
Organophosphorus Compounds
Schistosomiasis
Cholinesterase Inhibitors
Microdialysis
Choline
Basal Forebrain
Pharmaceutical Preparations
Oral Administration
Therapeutics
Brain

All Science Journal Classification (ASJC) codes

  • Behavioral Neuroscience

Cite this

@article{8e695cf4b4dc42c3854b354259813565,
title = "Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats",
abstract = "Several studies have indicated the possibility of using cholinesterase (ChE) inhibitors as therapeutic drugs for Alzheimer's disease. Metrifonate (MTF) is an organophosphorus compound that has been used in the treatment of schistosomiasis. In this study, we investigated the effects of MTF on the impairment of learning and memory, decreased ChE activity and extracellular acetylcholine (ACh) levels in basal forebrain (BF)-lesioned rats. The oral administration of MTF improved the BF-lesion-induced impairment of performance on passive avoidance task. Further, MTF reduced ChE activity in the cerebral cortex. In vivo brain microdialysis studies showed that MTF significantly increased the release of ACh, but decreased that of choline (Ch) in the cerebral cortex of BF-lesioned rats. These results indicated that MTF ameliorates the impairment of performance on passive avoidance task in BF-lesioned rats by increasing the extracellular ACh levels by inhibiting ChE. This suggested that MTF may be useful as a therapeutic drug for Alzheimer's disease.",
author = "Akio Itoh and Atsumi Nitta and Mitsuhiko Hirose and Takaaki Hasegawa and Toshitaka Nabeshima",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0166-4328(97)86062-7",
language = "English",
volume = "83",
pages = "165--167",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1-2",

}

Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats. / Itoh, Akio; Nitta, Atsumi; Hirose, Mitsuhiko; Hasegawa, Takaaki; Nabeshima, Toshitaka.

In: Behavioural Brain Research, Vol. 83, No. 1-2, 01.01.1997, p. 165-167.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats

AU - Itoh, Akio

AU - Nitta, Atsumi

AU - Hirose, Mitsuhiko

AU - Hasegawa, Takaaki

AU - Nabeshima, Toshitaka

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Several studies have indicated the possibility of using cholinesterase (ChE) inhibitors as therapeutic drugs for Alzheimer's disease. Metrifonate (MTF) is an organophosphorus compound that has been used in the treatment of schistosomiasis. In this study, we investigated the effects of MTF on the impairment of learning and memory, decreased ChE activity and extracellular acetylcholine (ACh) levels in basal forebrain (BF)-lesioned rats. The oral administration of MTF improved the BF-lesion-induced impairment of performance on passive avoidance task. Further, MTF reduced ChE activity in the cerebral cortex. In vivo brain microdialysis studies showed that MTF significantly increased the release of ACh, but decreased that of choline (Ch) in the cerebral cortex of BF-lesioned rats. These results indicated that MTF ameliorates the impairment of performance on passive avoidance task in BF-lesioned rats by increasing the extracellular ACh levels by inhibiting ChE. This suggested that MTF may be useful as a therapeutic drug for Alzheimer's disease.

AB - Several studies have indicated the possibility of using cholinesterase (ChE) inhibitors as therapeutic drugs for Alzheimer's disease. Metrifonate (MTF) is an organophosphorus compound that has been used in the treatment of schistosomiasis. In this study, we investigated the effects of MTF on the impairment of learning and memory, decreased ChE activity and extracellular acetylcholine (ACh) levels in basal forebrain (BF)-lesioned rats. The oral administration of MTF improved the BF-lesion-induced impairment of performance on passive avoidance task. Further, MTF reduced ChE activity in the cerebral cortex. In vivo brain microdialysis studies showed that MTF significantly increased the release of ACh, but decreased that of choline (Ch) in the cerebral cortex of BF-lesioned rats. These results indicated that MTF ameliorates the impairment of performance on passive avoidance task in BF-lesioned rats by increasing the extracellular ACh levels by inhibiting ChE. This suggested that MTF may be useful as a therapeutic drug for Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=19244372524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244372524&partnerID=8YFLogxK

U2 - 10.1016/S0166-4328(97)86062-7

DO - 10.1016/S0166-4328(97)86062-7

M3 - Article

C2 - 9062677

AN - SCOPUS:19244372524

VL - 83

SP - 165

EP - 167

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1-2

ER -